Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Allogeneic bone marrow transplantation].

H Shibata

    [Rinsho Ketsueki] the Japanese Journal of Clinical Hematology
    |August 1, 1989
    PubMed
    Summary
    This summary is machine-generated.

    Allogeneic stem cell transplant patients with leukemia showed varying survival rates. Graft-versus-host disease (GVHD) may reduce leukemia relapse, but interstitial pneumonia remains a risk.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Gene expression of angiotensin II receptor in blood cells of Cushing's syndrome.

    Hypertension (Dallas, Tex. : 1979)·1995
    Same author

    Attenuation of glycogenolytic action of activin A in intact rat liver.

    The American journal of physiology·1995
    Same author

    [Ictal electroencephalographic recordings of patients with seizure].

    Rinsho byori. The Japanese journal of clinical pathology·1995
    Same author

    [Pharmacological and biochemical investigation of intracavital fluorinated pyrimidine chemotherapy].

    Gan to kagaku ryoho. Cancer & chemotherapy·1995
    Same author

    Expression of calcium-permeable cation channel CD20 accelerates progression through the G1 phase in Balb/c 3T3 cells.

    The Journal of biological chemistry·1995
    Same author

    [Clinicopathological studies of anti-HCV P1P4 core antibody].

    Rinsho byori. The Japanese journal of clinical pathology·1995
    Same journal

    [Rinsho ketsueki] The Japanese journal of clinical hematology·2026
    Same journal

    [Rinsho ketsueki] The Japanese journal of clinical hematology·2026
    Same journal

    [Rinsho ketsueki] The Japanese journal of clinical hematology·2026
    Same journal

    [Recent advances in pathogenesis, diagnosis, and therapeutic strategies for POEMS syndrome].

    [Rinsho ketsueki] The Japanese journal of clinical hematology·2026
    Same journal

    [Recent advances in management of systemic AL amyloidosis].

    [Rinsho ketsueki] The Japanese journal of clinical hematology·2026
    Same journal

    [Treatment strategies for relapsed or refractory multiple myeloma: proposals for optimal treatment sequencing].

    [Rinsho ketsueki] The Japanese journal of clinical hematology·2026
    See all related articles

    Area of Science:

    • Hematology
    • Oncology
    • Immunology

    Context:

    • Allogeneic stem cell transplantation (SCT) is a crucial treatment for leukemia.
    • Survival rates vary significantly based on leukemia type and patient phase.
    • Graft-versus-host disease (GVHD) and post-transplant complications impact outcomes.

    Purpose:

    • To analyze long-term survival rates in allogeneic SCT recipients for leukemia.
    • To investigate the relationship between GVHD and survival/relapse.
    • To identify effective prophylaxis strategies for complications like interstitial pneumonia.

    Summary:

    • Survival probabilities were 63% (ALL), 64% (ANL), and 40% (CML).
    • GVHD, particularly combined acute and chronic, correlated with lower relapse rates (15.9%), suggesting a graft-versus-leukemia (GVL) effect.

    Related Experiment Videos

  • Interstitial pneumonia occurred in 32% of patients, with a 53% mortality rate.

    • Impact:

    • Findings highlight GVHD's potential dual role in leukemia treatment, offering GVL while impacting survival.
    • Effective prophylaxis strategies, including TBI dose modification, CMV-negative platelets, and anti-CMV globulin, are identified.
    • Colony-stimulating factor aids in reducing granulopenic periods, thereby preventing infections post-transplantation.